Physician profile
Walter O Whitley
NPI 1013976711
$546,379.62
in general payments reported to CMS, 2019-2025
46 companies · $109K in 2025
The $109K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $51K · 2021: $50K · 2022: $87K · 2023: $77K · 2024: $97K · 2025: $109K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $94K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82K · Consulting Fee: $61K · Travel and Lodging: $21K · Food and Beverage: $18K · Honoraria: $7,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $94,400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,645.50 |
| Consulting Fee | $60,646.50 |
| Travel and Lodging | $21,357.62 |
| Food and Beverage | $17,643.55 |
| Honoraria | $7,243.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $89,281.21 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Alcon Vision LLC | $72,174.72 | 2019-2025 | Tryptyr, Systane, Eysuvis |
| Sun Pharmaceutical Industries INC. | $69,763.71 | 2019-2025 | Cequa, Bromsite, Xelpros |
| Tarsus Pharmaceuticals, INC. | $49,671.62 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $34,425.54 | 2022-2025 | Tyrvaya |
| Dompe US, INC. | $28,350.24 | 2019-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $26,061.03 | 2019-2023 | |
| Abbvie INC. | $25,006.29 | 2022-2025 | Vuity, Alphagan P, Lumigan |
| Sight Sciences, INC. | $24,216.00 | 2019-2025 | Tearcare System, Omni Surgical System, Sion Surgical Instrument |
| Allergan, INC. | $23,038.41 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $20,591.97 | 2019-2022 | |
| Shire North American Group INC | $14,079.84 | 2019 | |
| Harrow Eye, LLC | $10,714.30 | 2024-2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $7,171.04 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $7,101.94 | 2019-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $6,770.10 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $5,762.93 | 2019-2022 | |
| Alcon Research LLC | $5,750.00 | 2024-2025 | Tryptyr |
| Apellis Pharmaceuticals, INC. | $4,939.16 | 2023-2025 | Syfovre, Syfovre |
| Tearlab Corp | $3,330.01 | 2019-2024 | Tearlab Osmolarity System, Scoutpro Osmolarity System |
| Biotissue Holdings INC. | $3,228.08 | 2019-2025 | |
| Thea Pharma INC. | $2,347.61 | 2022-2025 | Iyuzeh |
| Horizon Therapeutics Plc | $2,316.61 | 2020-2023 | Tepezza |
| Vertical Pharmaceuticals, LLC | $2,150.00 | 2020 | |
| Quidel Corporation | $1,328.90 | 2019-2022 | |
| Glaukos Corporation | $1,249.40 | 2019-2024 | Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Iaccess Precision Blade, Photrexa Cross-Linking Kit |
| Beaver-Visitec International, INC. | $1,000.00 | 2019 | |
| Carl Zeiss Meditec, INC. | $846.34 | 2019-2023 | Humphrey Field Analyzer (Hfa3), Clarus, Cirrus Hd-Oct |
| Mallinckrodt Hospital Products INC. | $756.44 | 2020-2025 | Acthar |
| Lumenis Be INC | $700.00 | 2022 | |
| Coopervision INC. | $664.39 | 2023 | Cvi Contact Lens |
| Amgen INC. | $347.73 | 2024-2025 | Tepezza |
| Notal Vision, INC. | $306.56 | 2022 | |
| New World Medical,INC. | $292.17 | 2019-2023 | |
| Topcon Healthcare, INC. | $216.53 | 2024 | |
| Carl Zeiss Meditec USA, INC. | $165.09 | 2022-2023 | Clarus |
| Rayner Intraocular Lenses Limited | $66.19 | 2023-2025 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Johnson & Johnson Vision Care, INC. | $38.92 | 2019 | |
| Immunogen, INC. | $32.50 | 2023 | Elahere |
| Regeneron Healthcare Solutions, INC. | $23.55 | 2025 | Eylea Hd |
| Lkc Technologies, INC. | $20.38 | 2023 | |
| Mallinckrodt Enterprises LLC | $19.41 | 2019 | |
| Alimera Sciences, INC. | $17.42 | 2024 | Yutiq, Iluvien |
| Rxsight INC | $17.23 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Maculogix, INC. | $16.87 | 2020 | |
| Lombart Brothers, INC. | $11.24 | 2023 | Opd-III |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$7,418.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Whitley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.